Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Arcutis Biotherapeutics (ARQT) Debt Ratio (2021 - 2025)

Arcutis Biotherapeutics (ARQT) has 5 years of Debt Ratio data on record, last reported at 0.31 in Q2 2025.

  • For Q2 2025, Debt Ratio changed N/A year-over-year to 0.31; the TTM value through Jun 2025 reached 0.31, changed N/A, while the annual FY2024 figure was 0.31, 48.02% down from the prior year.
  • Debt Ratio reached 0.31 in Q2 2025 per ARQT's latest filing, down from 0.31 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.69 in Q3 2023 and bottomed at 0.18 in Q4 2021.
  • Average Debt Ratio over 5 years is 0.42, with a median of 0.41 recorded in 2022.
  • Peak YoY movement for Debt Ratio: surged 162.19% in 2023, then plummeted 48.02% in 2024.
  • A 5-year view of Debt Ratio shows it stood at 0.18 in 2021, then skyrocketed by 148.33% to 0.44 in 2022, then surged by 34.29% to 0.59 in 2023, then tumbled by 48.02% to 0.31 in 2024, then decreased by 0.22% to 0.31 in 2025.
  • Per Business Quant database, its latest 3 readings for Debt Ratio were 0.31 in Q2 2025, 0.31 in Q1 2025, and 0.31 in Q4 2024.